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Abstract: (250 words) 68 
Osteochondral lesions, resulting from osteochondritis dissecans, are problematic to 69 
treat and present a significant challenge for clinicians. The aims of this study were to 70 
investigate the use of a scaffold-assisted microfracture approach, employing a novel 71 
multi-layered collagen-based osteochondral graft substitute in the treatment of severe 72 
osteochondritis dissecans of both lateral femoral trochlear ridges in an equine athlete, 73 
and to assess the potential of this novel scaffold to enhance repair of the osteochondral 74 
unit. A 15-month-old female filly presented with large osteochondritis dissecans 75 
lesions involving both femoral lateral trochlear ridges. After routine arthroscopic 76 
debridement and microfracture of the subchondral bone, multi-layered osteochondral 77 
defect repair scaffolds were implanted into the fragmentation beds in both left and right 78 
femoropatellar joints via mini-arthrotomy. Exploratory arthroscopy 5 months post-79 
implantation revealed smooth cartilaginous repair tissue, contiguous with adjacent 80 
cartilage, covering the defect. At 22-month follow up, the filly had no signs of lameness 81 
and was exercising at her intended level. Radiographically, although still slightly 82 
flattened, the femoral trochlear ridges were smooth, with no evidence of osteoarthritis. 83 
Ultrasonographically the defects were filled with bone and covered with an overlying 84 
cartilaginous layer, with the trochlear ridge contour almost entirely restored. This report 85 
demonstrates the effective clinical use of this novel multi-layered osteochondral defect 86 
repair scaffold in the treatment of osteochondritis dissecans of an equine athlete. The 87 
successful repair achieved here using this novel scaffold in an equine patient with large 88 
bilateral lesions shows the potential for clinical translation in the treatment of human 89 
patients presenting with osteochondral defects.  90 
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1. Introduction 91 
Repair of articular cartilage defects, occurring as a result of osteoarthritis, fracture, 92 
fragmentation, or surgical debridement of osteochondritis dissecans (OCD) lesions or 93 
subchondral bone cysts, represents a significant challenge for orthopaedic surgeons. 94 
Articular cartilage regeneration following injury is impaired by inherently poor 95 
vascular supply and the limited cellular content of hyaline cartilage (Nixon et al., 2011). 96 
Greater challenges present with larger defects and with subchondral bone involvement 97 
and currently no ‘gold standard’ technique exists for repair of such defects.  98 
Osteochondritis dissecans (OCD), a disruption of endochondral ossification, is a 99 
common orthopaedic developmental disease in many species, including humans and 100 
horses, and results in separation and instability of the overlying articular cartilage. OCD 101 
affects 10 to 30% of the equine population, depending on breed and joint (Desjardin et 102 
al., 2014) and as such is a major concern in the horse industry (Jeffcott, 1996). In 103 
humans, OCD is less common, with prevalence estimated at 15 to 21 per 100,000 104 
(Hughston et al., 1984), and defects most commonly occurring on the femoral condyles 105 
(Pascual-Garrido et al., 2009). Arthroscopic debridement of OCD lesions is the primary 106 
surgical strategy to facilitate healing in horses (Van Weeren and Jeffcott, 2013; 107 
McIlwraith, 2013; McIlwraith et al., 2015). Prognosis is inversely proportionate to the 108 
lesion’s size; with lesions in excess of 40 mm long carrying a 54% chance of achieving 109 
expected athletic performance with arthroscopic debridement alone (Foland et al., 110 
1992). In order to enhance repair of OCD lesions in veterinary patients, similar 111 
approaches to those used in human surgery have been applied. Autologous 112 
osteochondral grafting (mosaicoplasty) has been used successfully in the repair of deep 113 
osteochondral defects resulting from debridement of subchondral bone cysts (Bodό et 114 
al., 2004; Bodό et al., 2014). Autologous chondrocyte implantation has shown success 115 
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in the healing of experimentally created full-thickness cartilage lesions (1.5cm 116 
diameter) in the lateral trochlear ridge of horses with improved histologic scores at 8 117 
weeks post-implantation (Nixon et al., 2011). However, debridement, with or without 118 
microfracture, remains the most commonly used treatment for OCD defects in horses 119 
for practical reasons (McIlwraith, 2013; McIlwraith et al., 2015; Frisbie et al., 1999). 120 
Equine models are currently recommended for preclinical assessment of new 121 
biomaterial-based strategies for cartilage repair as they provide the closest 122 
approximation to humans in terms of cartilage thickness (Malda et al., 2012). A number 123 
of experimental studies have thus been carried out using equine models to assess the 124 
regenerative potential of new biomaterials (Frisbie et al., 2008; Frisbie et al., 2009; 125 
Kon et al., 2010b; Nixon et al., 2011; Seo et al., 2013). Few studies have been carried 126 
out in horses to investigate the use of these biomaterial-based strategies for the repair 127 
of osteochondral defects resulting from injury or disease, such as OCD. In one case, 128 
Tsuzuki et al. (2013) showed fibrocartilaginous repair of an OCD lesion using a gelatin 129 
β-tricalcium phosphate sponge, impregnated with platelet-rich plasma, bone 130 
morphogenetic protein-2, mesenchymal stem cells. While the biomaterial-based 131 
solutions investigated to date have shown some potential, generally fibrocartilaginous 132 
tissue results and an urgent need remains for repair strategies that will facilitate long 133 
lasting repair of the osteochondral unit.  134 
To meet this need a biocompatible, biomimetic and highly porous (> 95%) multi-135 
layered collagen-based scaffold has been developed within the Tissue Engineering 136 
Research Group in the Royal College of Surgeons in Ireland (Gleeson et al., 2010; 137 
Levingstone et al., 2014). This novel construct mimics the inherent graduated structure 138 
of healthy osteochondral tissue: a bone layer composed of type I collagen and 139 
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hydroxyapatite (HA), with demonstrated osteogenic properties (David et al., 2015; 140 
Gleeson et al., 2010; Murphy et al., 2014), an intermediate layer composed of type I 141 
collagen and hyaluronic acid (HyA) and a cartilaginous region composed of type I 142 
collagen, type II collagen and HyA. The properties of the material are designed to 143 
provide the biological and biomechanical cues required to encourage infiltration of host 144 
cells from the bone marrow and to promote differentiation of these cells towards the 145 
required lineage in each region. The regenerative potential of this scaffold has been 146 
demonstrated in vitro and in vivo in both rabbits and goats (Levingstone et al., 2014; 147 
Levingstone et al., Under review a; Levingstone et al., Under review b).  148 
This study describes the use of this novel, multi-layered osteochondral scaffold in the 149 
treatment of bilateral OCD of the lateral trochlear ridges in the femoropatellar joints of 150 
an Irish Sport Horse. The extent of the osteochondral lesions in this horse was such that 151 
the prognosis for future athleticism was poor. Loss of articular cartilage and destruction 152 
of subchondral bone architecture, resulting from the required curettage of the lesions, 153 
was expected to disrupt the contour of the trochlear ridges. The degree of disruption 154 
would likely have led to instability in the joint, resulting in osteoarthritis (McIlwraith, 155 
2013). The aims of this study were to assess the potential of a scaffold-assisted 156 
microfracture approach, combining microfracture with implantation of a novel multi-157 
layered collagen-based scaffold to enhance the repair of the osteochondral unit of both 158 
lateral femoral trochlear ridges in a horse affected by OCD. 159 
 160 
2. Materials and methods 161 
2.1 Case description  162 
A 15-month-old female Irish Sport Horse presented to the University College Dublin 163 
Veterinary Hospital (UCDVH) with severe effusion of both femoropatellar (FP) joints. 164 
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Radiographic examination of the FP joints demonstrated marked intra-articular soft 165 
tissue swelling and the contour of the middle and proximal aspects of the lateral 166 
trochlear ridge (LTR) of the distal femur of both the left and right hind limbs was 167 
markedly irregular, with large areas of resorption deep in the subchondral bone. Non-168 
detached osteochondral fragments were visible in these lesions. There was a small, 169 
mineralized fragment detached from the parent bone in the cranial aspect of the right 170 
FP joint (Figure 1). The proximodistal length and craniocaudal depth of the 171 
osteochondral lesions on the left side were 46 mm and 22 mm, respectively, and on the 172 
right side were 49 mm and 23 mm, respectively. Ultrasonographic (US) examination 173 
confirmed the presence of marked synovial effusion of the FP joints. The surface of the 174 
osteochondral unit was undulating, irregular in shape and thickness, and was deeply 175 
fissured. Non-detached osteochondral fragments were noted (Figure 2). The 176 
mediolateral measurement of the lesion was 20 mm for the left trochlea and 19 mm for 177 
the right trochlea. A free ossified fragment was found in the right FP joint. These 178 
changes were consistent with a diagnosis of OCD and were classified according to the 179 
International Cartilage Repair Society (ICRS) OCD lesion classification scale as grade 180 
IV (i.e. lesions with a complete discontinuity, with a dislocated fragment or a loose 181 
fragment within the bed; grade IV is the most severe grade) (Brittberg and Winalski, 182 
2003). 183 
 184 
2.2 Scaffold fabrication 185 
Multi-layered scaffold sheets, 60 mm x 60 mm x 20 mm, were fabricated using a unique 186 
iterative layering fabrication method (Levingstone et al., 2014). The multi-layered 187 
scaffold consisted of a bone layer containing type I collagen (Col1) [Southern Lights 188 
Biomaterials, Napier, New Zealand] and hydroxyapatite (HA) [Plasma Biotal, UK], an 189 
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intermediate layer, consisting of Col1 and hyaluronic acid sodium salt derived from 190 
Streptococcus equi (HyA) [Contipro, Dolní Dobrouč, Czech Republic] and a cartilage 191 
layer, consisting of Col1, type II collagen (Col2) [porcine type II collagen, Symatese, 192 
Chaponost, France] and HyA. Scaffolds were freeze-dried as previously described in 193 
order to produce a multi-layered scaffold with seamless layer integration (Levingstone 194 
et al., 2014; Gleeson et al., 2009). Following freeze-drying the scaffold was cross-195 
linked using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC)/N-196 
hydroxysuccinimide (NHS) (Sigma–Aldrich, Arklow, Ireland) at a concentration of 6 197 
mM EDAC g-1 of collagen, and a 5:2 M ratio of EDAC:NHS for 2 hours at room 198 
temperature (Haugh et al. 2011). Scaffolds were then dehydrothermally (DHT) cross-199 
linked in a vacuum oven (VacuCell, MMM, Germany) at 105°C and a pressure of 50 200 
mTorr for 24 hours to generate cross-links through a condensation reaction and also to 201 
sterilise the scaffolds.  202 
 203 
2.3  Surgical procedure 204 
The horse was anaesthetized and placed in dorsal recumbency. A routine arthroscopic 205 
approach to the left FP joint was made between the middle and lateral patellotibial 206 
ligaments (McIlwraith et al., 2015). The instrument portal was made through stab 207 
incision lateral to the lateral patellotibial ligament. The cartilage covering the middle 208 
and proximal parts of the LTR was undulating, irregular and deeply fissured with non-209 
detached but unstable fragments (Figure 3). The cartilage lesions were debrided and the 210 
subchondral bone was curetted until solid, bleeding bone was encountered. 211 
Microfracture of the subchondral bone was carried out with a 30° microfracture pick 212 
(Sontec Instruments, Colorado, USA) and a mallet, as previously described (Frisbie et 213 
al., 1999). Debris and small fragments were then lavaged from the FP joint with the aid 214 
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of a third portal created in the suprapatellar pouch with an 11 mm laparoscopic cannula 215 
(Vinardell et al., 2008; McNally et al., 2011). A second surgical team performed an 216 
identical procedure concurrently on the right FP joint. As the defects were extensive 217 
and the prognosis for athleticism was poor, a tissue engineering approach was applied 218 
in this horse. To enable scaffold implantation a small arthrotomy (50 mm) was created 219 
directly over the LTR of each stifle (lateral to the lateral patellotibial ligament). Self-220 
retaining retractors were placed to expose the fragmentation bed (Figure 4). A sterile 221 
foil template was press-fitted into the fragmentation bed and the sterilized multi-layered 222 
scaffold sheets were cut to match the size and shape of the templates. The scaffolds 223 
were then soaked in sterile saline and pressed gently into the defect. The left scaffold 224 
was secured with a combination of fibrin glue (Tisseel, Baxter, Dublin, Ireland) and 225 
cyanoacrylate glue (Histoacryl, B Braun Medical, Dublin, Ireland) (Figure 4). The 226 
scaffold in the right defect was retained using a press-fit approach. Closure of the 227 
arthrotomy was performed in five layers and the arthroscopy portals were closed in one 228 
layer. After closure a combination of morphine [Morphine Sulphate, Mercury Pharma] 229 
10 mg, bupivacaine [Marcain, AstraZeneca] 200 mg and gentamicin [Gentaject, 230 
Franklin] 500 mg was injected intra-articularly. Sterile adhesive dressings were placed 231 
prior to recovery from anesthesia. 232 
 233 
2.4 Post-operative evolution 234 
The Anderson Sling system [Charles D. Anderson, Care for Disabled Animals, Potter 235 
Valley, CA] was used in recovery to support the horse until fully conscious and weight 236 
bearing on all limbs, reducing stress on the scaffolds (Taylor et al., 2005). Perioperative 237 
antibiotics (Procaine penicillin [Depocillin, Interchem] 22,000 IU/kg IM q 12 hours 238 
and gentamicin sulphate [Gentaject, Franklin] 6.6 mg/kg IV q 24 hours) were continued 239 
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for five days. Non-steroidal anti-inflammatory (phenylbutazone [Phenylarthrite, 240 
Vetoquinol] 2.2 mg/kg IV q 12 hours) was continued for five days on a tapering dose. 241 
The horse was discharged from the hospital on day eight post-operatively, with 242 
recommendations to remove the skin sutures on day 12-14 post-surgery and to restrict 243 
exercise to a large box stall for the first 6 weeks, then to walk the horse in hand for 6 244 
weeks and finally to turn her out to a paddock for the following 3 months. 245 
Follow up US was performed at 8 days, 5 months and 22 months postoperatively. 246 
Follow up radiographic examination was performed at 5 and 22 months 247 
postoperatively. A radiographic scoring system, devised by Sparks et al., (2011) was 248 
used to evaluate radiographs at 5 and 22 months. This system assessed the postoperative 249 
radiographic appearance of the subchondral filling (scale: 0 = No evidence of prior 250 
OCD to 3 = Worsening/progression of the subchondral lucencies) and subchondral 251 
bone contour (scale: 0 = smooth, contiguous to 4 = free floating mineralized bodies).  252 
 253 
3. Results 254 
3.1 Post-operative outcome 255 
The horse recovered uneventfully from anesthesia using the Anderson Sling system. 256 
Moderate effusion of the FP joints was observed at suture removal 12 days post-257 
operatively. The incisions were intact at this time. Eight days later, both arthrotomy 258 
sites began discharging clear serous fluid and dehisced fully over the next 2 days. The 259 
horse was treated with trimethoprim-sulphadiazine [Noroprim granules, Norbrook] (30 260 
mg/kg q 12 hours per os) for 2 weeks from the onset of dehiscence. The wounds were 261 
cleaned daily with dilute chlorohexidine solution and had fully healed 7 weeks later. 262 
No fever or signs of lameness developed during this period. Exercise was restricted to 263 
box rest during the entire management of this complication (total of 10 weeks). Once 264 
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wound healing was achieved, a walking programme was introduced consisting of five 265 
minutes walking in hand daily for 1 week with the duration of daily walks increased by 266 
five minutes per week. This was continued for 6 weeks. The horse was then turned out 267 
in a small paddock until undergoing a second bilateral FP arthroscopy. Twenty-two 268 
months after scaffold implantation the horse was sound and in full training: ridden 269 
exercise under saddle at walk, trot, canter and jumping. There was evidence of mild 270 
joint effusion and small scars were present at the arthrotomy sites.  271 
 272 
3.2  Diagnostic imaging  273 
Ultrasonographic examination performed eight days postoperatively showed the 274 
subchondral bone to have a concave contour, representing the area of the LTR that had 275 
been debrided (Figure 2). These defects were filled with homogeneous echogenic 276 
material, which was determined, based on previous experience, to be due to the 277 
presence of the scaffolds. The scaffold was well fixated and in line with joint surface 278 
on the left side, and in line with the joint surface, but was partially dislodged 279 
distolaterally on the right side. On ultrasonographic examination, 5 months 280 
postoperatively the defects in the LTRs resulting from the curettage were still evident; 281 
however, the defects were noticeably shallower. The defects were smooth and filled 282 
with mildly echogenic heterogeneous material. Ultrasonography, 22 months 283 
postoperatively, showed mild effusion of the left FP joint with some synovial 284 
proliferation. The subchondral defects, created by the surgical debridement, into which 285 
the scaffolds had been positioned, were no longer evident. These areas were instead, 286 
filled with bone as evidenced by a mildly undulating hyperechogenic line, contiguous 287 
with adjacent normal subchondral bone. Repair of the overlying cartilaginous layer was 288 
also evident. While this cartilage layer was thinner than the surrounding cartilage tissue, 289 
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the echogenicity was largely similar to that of the adjacent normal hyaline cartilage. 290 
Some areas of increased echogenicity were observed within the repair tissue indicating 291 
that some tissue remodeling may still be ongoing. 292 
Radiographic examination performed at 5 months demonstrated modest reduction in 293 
intra-articular soft tissue swelling. The subchondral lucencies within the LTRs were 294 
reduced in size but still apparent. Lucent areas were less well defined by a rim of 295 
sclerosis. The proximal and distal limits of the defects were smooth and round. 296 
Evaluation of the radiographs of both left and right sides showed Grade 2 subchondral 297 
filling (i.e. <50% resolution of lucencies) and Grade 2 subchondral contour both (i.e. 298 
mild/moderate irregularities). The length (proximodistal) and depth (craniocaudal) of 299 
the osteochondral lesions at 5 months in the left were 46 mm and 17 mm, and for the 300 
right were 40 mm and 18 mm, respectively. Radiographic examination performed 22 301 
months postoperatively showed no evidence of osteoarthritis and no free bodies. The 302 
LTRs were smooth, although with a flatter appearance than normal. Repair of the 303 
subchondral bone was evident; however, a small area of incomplete healing was seen 304 
to persist on the left side. Assessment of the radiographs at 22 months postoperatively 305 
(Figure 1) showed Grade 1 subchondral filling (i.e. >50% resolution of subchondral 306 
lucencies) and Grade 1 subchondral contour (i.e. flattened). The length (proximodistal) 307 
and depth (craniocaudal) of the osteochondral lesions at 22 months in the left were 33 308 
mm and 17 mm, and for the right were 35 mm and 17 mm, respectively.  309 
 310 
3.3 Exploratory arthroscopy 311 
The horse was represented to UCDVH 5 months postoperatively due to mild persistent 312 
effusion of the femoropatellar joints. The horse did not exhibit lameness at the walk or 313 
trot. Small scars (20 mm x 10 mm) were present at site of the previous arthrotomies. 314 
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The FP joints were explored arthroscopically under general anaesthesia as described 315 
earlier. Repair tissue within the graft implantation sites was visualized arthroscopically 316 
(Figure 3) and scored using the International Cartilage Repair Society (ICRS) cartilage 317 
repair assessment tool as shown in Table 1 (Brittberg and Peterson, 1998; Peterson et 318 
al., 2000). The sites of the scaffold implantation were covered by immature cartilage 319 
that was contiguous with the adjacent normal cartilage along the entire perimeter 320 
(Figure 3). The cartilage was smooth although the repair tissue maintained a lower 321 
profile than the trochlear ridge proximally and distally. An area of proliferative 322 
synovitis/granuloma covered the joint capsule at the site of the arthrotomies. This was 323 
more marked in the left femoropatellar joint. Macroscopic assessment of repair tissue 324 
using the ICRS scoring system resulted in a score of 10/12 for each defect site, placing 325 
them in the Grade II (nearly normal) category. Exploration of the entirety of the joint 326 
demonstrated an absence of debris or fragments. The arthroscopy portals were closed 327 
and sterile adhesive dressings were placed prior to recovery. The filly recovered 328 
uneventfully from anesthesia using the Wilderjans rope recovery system (Niimura del 329 
Barrio et al., Under review).  330 
 331 
3.4 Synovial fluid analysis  332 
Synovial fluid analysis 5 months postoperatively showed that synovial fluid from both 333 
joints was subjectively less viscous than normal synovial fluid with nucleated cell count 334 
from the left and right femoropatellar joints found to be normal (0.3x109 cells/L) and 335 
mildly elevated (3.6x109 cells/L), respectively. The percentage neutrophils from the left 336 
and right femoropatellar joints were 7% and 12%, respectively. The total protein from 337 
the left and right FP joints was 8 g/L and 12 g/L, respectively and synovial fluid serum 338 
amyloid A (SAA) levels was less than 5 μg/mL for both joints. Percentage neutrophils, 339 
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total protein and synovial fluid SAA levels were normal in both joints (Stack et al., 340 
Under review).  341 
 342 
4. Discussion 343 
This study demonstrates the successful use of a multi-layered collagen-based scaffold 344 
in the treatment of large OCD lesions in both femoral trochlear ridges of an equine 345 
athlete. The results show the potential of this scaffold to promote repair of bone and 346 
cartilage within the defect sites, leading to restoration of the joint surface. Exploratory 347 
second-look arthroscopy, 5 months post scaffold placement, revealed that the defects 348 
were covered with immature cartilage, contiguous with the surrounding cartilage, 349 
although the profile of repair tissue was slightly below the normal joint surface. At 22 350 
months post-implantation, the horse was undergoing a full athletic regimen. 351 
Radiographic and US examinations 22 months postoperatively confirmed filling of the 352 
subchondral bone defects with new bone and restoration of the integrity of the joint 353 
surface. 354 
Osteochondritis dissecans, a manifestation of osteochondrosis (OC), is the most 355 
common cause of lameness and the most common indication for surgery in the equine 356 
stifle joint (van Weeren, 2012). It occurs due to derangement of the normal 357 
endochondral ossification process and results in irregular, thickened cartilage, necrosis 358 
of the underlying subchondral bone, and often, fissuring and fragmentation of the 359 
affected area of cartilage (Laverty and Girard, 2013; Sparks et al., 2011). The origin is 360 
still unclear, however it is commonly accepted that there are a number of contributing 361 
factors including dietary imbalance, biomechanical factors, genetic susceptibility, 362 
declining metabolic rate in the young adult and physiological factors; such as growth, 363 
conformation and hormonal imbalance (Desjardin et al., 2014; Erickson et al., 2013; 364 
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Laverty and Girard, 2013; Van Weeren, 2012). Clinical signs develop when the joint 365 
surface is breached by the dissecting lesion or when a fragment completely detaches, 366 
leading to synovitis, varying degrees of lameness and development of osteoarthritis 367 
(Desjardin et al., 2014). The horse presented in this study had no history of trauma and 368 
was free from OCD in the other predilection sites. The specific aetiology in this horse 369 
is undefined, as is often the case. 370 
Currently, surgical removal of OCD fragments, curettage of necrotic bone and cartilage 371 
alone, or in conjunction with microfracture of the subchondral bone, remains the 372 
recommended clinical approach for treatment of OCD defects in horses (Foland et al., 373 
1992; Frisbie et al., 1999; McIlwraith, 2013; McIlwraith et al., 2015). Microfracture 374 
alone has shown clinical success; however, often repair tissue is composed of 375 
fibrocartilage rather than hyaline cartilage and can break down over time (Miller et al., 376 
2004; Steadman et al., 2003). In the case presented here, the OCD lesions were large 377 
with extensive lytic lesions in the subchondral bone and thus, the prognosis for 378 
athleticism using standard approaches was poor (Foland et al., 1992; Sparks et al., 379 
2011). Debridement, with or without microfracture, would likely have resulted in joint 380 
instability and osteoarthritis as a sequel (McIlwraith and Nixon, 1996). The large size 381 
of the lesion precluded use of osteochondral grafting procedures, such as mosaicoplasty 382 
(Bodό et al, 2014), as the osteochondral tissue required to fill the defects could not have 383 
been harvested without substantial donor site morbidity. Autologous cartilage 384 
implantation (ACI) (Frisbie et al, 2008; Nixon et al, 2011) was deemed inappropriate 385 
due to the extent of diseased subchondral bone requiring debridement, and the 386 
requirement for an additional surgery to harvest cartilage for expansion. Thus in this 387 
study, a scaffold-assisted microfracture approach was utilised. The technique involved 388 
curettage of diseased cartilage and bone, combined with microfracture of the 389 
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subchondral bone, followed by implantation of a novel multi-layer osteochondral defect 390 
repair scaffold. Similar enhanced microfracture procedures have shown promise in the 391 
repair of chondral and osteochondral lesions in humans (Anders et al., 2013; 392 
Dhollander et al., 2012; Gille et al., 2010; Kon et al., 2014; Kusano et al., 2012). Thus, 393 
we hypothesised that the use of this approach would lead to enhanced regenerative 394 
responses within the defect sites. To the authors’ knowledge, this is the first time this 395 
scaffold-assisted microfracture approach has been used to treat OCD lesions of the 396 
distal femoral trochlear ridges in horses. Additionally, this is the first use of this multi-397 
layered osteochondral defect repair scaffold in the treatment of disease in a veterinary 398 
patient. 399 
The multi-layered scaffold employed in this case has been designed for osteochondral 400 
defect repair, and specifically for use as an off-the-shelf, cell-free biomaterial for press-401 
fit implantation into an osteochondral defect site. The use of microfracture here serves 402 
to enable cells, most notably stem cells, from the bone marrow to populate the defect. 403 
The scaffold was seen to fill with blood on implantation demonstrating that the 404 
hydrophilic nature and porous scaffold architecture enables infiltration of blood and 405 
cells from the host bone marrow through the scaffold’s seamlessly integrated multi-406 
layered structure (Figure 4). Clot formation within the defect also results in improved 407 
retention of the scaffold within the defect site (Frisbie et al., 1999). The incorporated 408 
extracellular matrix macromolecules, and scaffold biostructural and biomechanical 409 
properties have been previously shown to direct the differentiation of mesenchymal 410 
stem cells (MSC) to produce bone, calcified cartilage and cartilage within the requisite 411 
regions of the defect site, with restoration of the anatomical tidemark and to result in 412 
joint regeneration (Levingstone et al., Under review a; Levingstone et al., Under review 413 
b). The scaffold demonstrated numerous advantages, including sufficient mechanical 414 
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strength, durability and flexibility to withstand surgical handling. It was easily cut to 415 
shape and sculpted to conform well to the debridement bed, so much so that in the right 416 
limb a press-fit implantation could be achieved. 417 
Successful clinical results were demonstrated using both press-fit and gluing fixation 418 
methods. Fixation poses a significant challenge for biomaterials in articular cartilage 419 
repair. Suturing has proved successful but is limited by technical challenges and the 420 
long surgery times required. Other potential fixation approaches include polydioxanone 421 
(PDS) staples (Frisbie et al., 2009) and PDS pins (Nixon et al., 2004; Sparks et al., 422 
2011). The scaffold employed here, once hydrated, becomes compliant with reduced 423 
mechanical strength, although still sufficient for surgical handling, this poses 424 
challenges for retention of staples, pins or sutures. Press-fit implantation offers 425 
advantages, such as reduced surgical time and avoidance of the need to include 426 
additional materials, and has been used successfully in small focal lesions (Levingstone 427 
et al., Under Review a; Levingstone et al., Under Review b); however larger lesions 428 
present greater challenges. In this case, ultrasound confirmed persistence of the scaffold 429 
within both defect sites eight days postoperatively. Incomplete fixation was observed 430 
on the right side with some detachment evident. However, despite this, the bulk of the 431 
scaffold remained in situ. Tissue glues, such as fibrin glue and cyanoacrylate glue, have 432 
demonstrated some success in scaffold fixation (Ayan et al 2007; Patel et al., 2010). 433 
The gluing approach employed here, using a combination of fibrin and cyanoacrylate 434 
glue proved more successful, with scaffold fixation observed ultrasonographically eight 435 
days postoperatively. This approach is thus recommended for fixation of this multi-436 
layered scaffold in large defects in the future. Recovery from anaesthesia was an 437 
important consideration to ensure protection of the scaffold in the initial postoperative 438 
phase. Use of the Anderson sling recovery system resulted in optimal recovery with 439 
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minimal flexion of the stifle joints. Furthermore, the use of the sling resulted in less 440 
tension and trauma to the laterally placed arthrotomy suture lines. 441 
On US examination at 5 months postoperatively, the defects were filled with slightly 442 
echogenic material. During exploratory arthroscopic surgery performed the following 443 
the day this was confirmed to be immature cartilage, with ICRS macroscopic scores 444 
placing it in the near normal category. Synovial fluid analysed 5 months postoperatively 445 
was normal in the left femoropatellar joint and showed signs of mild inflammation in 446 
the right. The reason for mild synovitis in the right femoropatellar joint is unclear but 447 
may be related to the arthrotomy site dehiscence and chronic synovial proliferation. 448 
The mild increase in nucleated cell count may also reflect the normal inflammatory 449 
process involved in healing of osteochondral defects. The lack of marked inflammatory 450 
response at any time during the study demonstrates the biocompatibility and safety of 451 
the scaffold. Modest radiographic healing was observed with the debridement bed 452 
slowly filling with new bone over time. Due to the size of the lesions in this case, it was 453 
not expected that the trochlear ridges would appear radiographically normal at any time 454 
point (McIlwraith and Nixon, 1996), thus the aim here was to improve the trochlear 455 
function and offer the horse an improved athletic prognosis. Healing was evidenced by 456 
the loss of the sclerotic rim demarcating the abnormal from normal subchondral bone; 457 
the new bone formation and the uniformity of the subchondral bone. In addition, there 458 
was no evidence of osteoarthritis. 459 
Ultrasound performed 22 months postoperatively revealed replacement of the deeper 460 
layers of the scaffolds with bone, and cartilage superficially. Whilst the original profile 461 
of the trochlear ridges had not been fully achieved, the articular surface of the LTRs 462 
was resurfaced and functional. These results demonstrate the benefits of the 463 
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osteoinductive properties of the base layer of the scaffold provided by the 464 
hydroxyapatite component and the chondrogenic properties of the top layer provided 465 
by the type II collagen and hyaluronic acid. Notably, the cartilage and bone healing 466 
observed here was achieved in the absence of additional chondrogenic or osteogenic 467 
growth factors or cells. A more complete evaluation of the quality of the cartilage repair 468 
and expected long term clinical function could have been made if the tissues were 469 
biopsied during the second surgery (Krishnan et al., 2008). However, this was not 470 
possible due to ethical considerations. While the cartilage covering the healed 471 
subchondral bone was functional at 22 months post-surgery, the long term durability of 472 
the repaired cartilage remains unknown. At 22 months postoperatively, the horse was 473 
performing athletically at its intended level, with no evidence of lameness. The reason 474 
for the persistence of some effusion and synovial hypertrophy in the left femoropatellar 475 
joint is not clear, but is likely to be related to the synovial proliferation and granuloma 476 
formation at the arthrotomy site. The use of an arthrotomy was necessary in order to 477 
provide sufficient accessibility to place the scaffolds, however, this resulted in some 478 
side issues as highlighted by the dehiscence of both arthrotomy sites; a recognised 479 
complication of arthrotomy in the horse (Trotter et al., 1983; Pascoe et al., 1980). 480 
Dehiscence was partial in this case with the multiple layer closure used enabling the 481 
joint capsule to remain intact and preventing development of synovial communication 482 
or herniation; however, permanent scarring of the area resulted. While arthroscopic 483 
implantation of this scaffold is not currently possible, it is likely that use of arthroscopic 484 
methods would have reduced the likelihood of these complications occurring. 485 
Arthroscopy has been shown to minimise trauma to surrounding tissues, decrease 486 
muscular deficits, decrease chances of wound infection and improve cosmetic 487 
outcomes (Jameson et al., 2011; McIlwraith et al., 2015; Small, 1993).  488 
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While equine models are recommended for preclinical assessment of new tissue 489 
engineering strategies for cartilage repair, few studies have been carried out in horses 490 
using tissue engineering strategies for the repair of cartilage defects resulting from 491 
injury or disease. This study provided the opportunity to treat a veterinary patient, while 492 
also providing important information for clinical translation. The promising results in 493 
this study demonstrate that the use of this novel multi-layered osteochondral defect 494 
repair scaffold in this scaffold-assisted microfracture procedure is an effective approach 495 
to promote enhanced filling of osteochondral defects, following curettage, in the 496 
treatment of OCD.  497 
 498 
5 Conclusions 499 
This case study investigated the use of a scaffold-assisted microfracture approach, 500 
employing a novel multi-layered collagen-based scaffold, designed for osteochondral 501 
defect repair in humans, in the treatment of large osteochondritis dissecans (OCD) of 502 
both lateral femoral trochlear ridges in a horse. Clinical follow-up at 5 and 22 months 503 
revealed almost complete filling of the subchondral bone defect, and restoration of a 504 
smooth articular surface to the trochlear ridges. These promising results demonstrate 505 
the effective clinical use of this novel multi-layered osteochondral defect repair scaffold 506 
in the promotion of enhanced filling of osteochondral defects following debridement in 507 
OCD. The successful functional repair of the complete osteochondral unit achieved 508 
here in an equine athlete with large bilateral lesions shows potential for clinical 509 
translation to human patients presenting with large osteochondral defects. 510 
 511 
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Figures 518 
  519 
Figure 1. Lateromedial radiographs of left and right femoropatellar joints before (A, B) 520 
and 22 months after arthroscopic debridement and scaffold placement (C, D). The 521 
contour of the lateral trochlear ridges of the distal femur of both the left and right hind 522 
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limbs were markedly irregular, with non-detached osteochondral fragments overlying 523 
large areas of cystic resorption deep in the subchondral bone (Lesion borders 524 
highlighted with white *). There was a small, free mineralized fragment in the cranial 525 
aspect of the right femoropatellar joint (white arrowhead). At 22 months 526 
postoperatively there is Grade 1 subchondral filling of the subchondral lucencies (i.e. 527 
>50% resolution) and the subchondral contour is smooth although slightly flattened 528 
(Grade 1) (black arrows).  529 
 530 
Figure 2. Ultrasonographic images of the left and right lateral trochlear ridges in both 531 
longitudinal (column 1 and 3) and transverse planes (column 2 and 4). Preoperatively 532 
(top row), the surface of the osteochondral unit was undulating, irregular in shape and 533 
thickness (white +), and was deeply fissured. At 8 days post implantation (middle row), 534 
the scaffold (white *) is in situ in the left limb and largely in situ in the right limb with 535 
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a small area of detachment distolaterally. At 22 months (the bottom row) the 536 
subchondral defects, created by the surgical debridement, into which the scaffolds had 537 
been positioned, were no longer evident. These areas were instead, filled with bone as 538 
evidenced by a mildly undulating hyperechogenic line (white arrows), contiguous with 539 
adjacent normal subchondral bone. Proximal is to the right in longitudinal views. 540 
Lateral is to the right in transverse views. 541 
 542 
 543 
Figure 3. Arthroscopic images of the left (A, C) and right (B, D) femoropatellar joints 544 
showing the lateral femoral trochlea (LTR) before debridement (top row) and during 545 
second-look arthroscopy five months later (bottom row). In A and B the cartilage 546 
covering the middle and proximal parts of the LTR was undulating, irregular and deeply 547 
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fissured (black arrowheads) with evidence of non-detached osteochondral fragments 548 
(OCD). In C and D repair tissue within the graft implantation sites scored 10/12 (nearly 549 
normal) according to the International Cartilage Repair Society (ICRS) cartilage repair 550 
assessment tool. The patella (P) is visible above the LTR. Black * mark the junction 551 
between normal and repair cartilage. 552 
 553 
Figure 4. The scaffolds were soaked in sterile saline and pressed gently into the defect 554 
via arthrotomy (A). The left scaffold was secured with a combination of fibrin glue 555 
(Tisseel, Baxter, Dublin, Ireland) and cyanoacrylate glue (Histoacryl, B Braun Medical, 556 
Dublin, Ireland) (B, C, D). Note the scaffolds becoming blood soaked on implantation 557 
(C and D).   558 
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Table 1: International Cartilage Repair Society (ICRS) cartilage repair assessment tool 559 
(Brittberg and Peterson, 1998; Peterson et al., 2000). This tool is used by surgeons to 560 
evaluate the macroscopic appearance of cartilage repair tissue following interventions 561 
such as ACI, subchondral drilling and microfracture and rates cartilage repair tissue as 562 
Grade IV (severely abnormal), Grade III (abnormal), Grade II (nearly normal) or Grade 563 
I (normal) based, on the degree of defect repair, degree of integration and macroscopic 564 
appearance. 565 
  Criteria Points 
Degree of Defect 
Repair 
Level with surrounding cartilage 
75% repair of defect depth 
50% repair of defect depth 
25% repair of defect depth 
0% repair of defect depth 
4 
3 
2 
1 
0 
Integration to 
Border Zone 
Complete integration with surrounding cartilage 
Demarcating border < 1mm 
3/4 of graft integrated, 1/4 with a notable border >1mm 
width 
1/2 of graft integrated with surrounding cartilage,1/2 
with a notable border > 1mm 
From no contact to 1/4 of graft integrated with 
surrounding cartilage 
4 
3 
2 
 
1 
0 
Macroscopic 
Appearance 
Intact smooth surface 
Fibrillated surface 
Small, scattered fissures or cracks 
Several, small or few but large fissures 
Total degeneration of grafted area 
4 
3 
2 
1 
0 
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Overall Score Grade I        normal 
Grade II       nearly normal 
Grade III      abnormal 
Grade IV      severely abnormal 
12 
11-8 
7-4 
3-1 
 566 
  567 
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